Marex Group’s STAAR Surgical STAA Stock Holding History

Marex Group’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32,560	Closed	-$1.55M	–	753
2024 Q2	$1.55M	Buy	+32,560	New	+$1.43M	0.04%	184

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marex Group's STAA Position: Q3 2024 in Review

Marex Group sold out of STAAR Surgical (STAA) in Q3 2024, closing a stake of 32,560 shares — an estimated $1.55M sold.

Marex Group first reported a position in STAA in Q2 2024 and held it in 1 quarter. The position peaked at $1.55M in Q2 2024. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

Marex Group reported no remaining STAAR Surgical position as of Q3 2024 after selling out during the quarter.
Marex Group sold 32,560 STAAR Surgical shares in Q3 2024, an estimated $1.55M.
Marex Group first reported a position in STAAR Surgical in Q2 2024 and held it in 1 quarter.
Marex Group's STAAR Surgical position peaked at $1.55M in Q2 2024.
236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Marex Group's 13F filing for Q3 2024, filed 7 Apr 2026.